Search research articles
Contact Us
Filters
Showing results (71-80 of 217) with videos related to
Page
of 22
Sort By:
BMJ Supportive & Palliative Care
|
September 2, 2017
Risk factors for falls in older patients with cancer
Xiaotao Zhang, Ming Sun, Suyu Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Joseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Blood Advances
|
April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies
Supawee Saengboon, Stefan Ciurea, Uday Popat, et al.
Leukemia & Lymphoma
|
January 4, 2018
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma
Ehsan Malek, Vinita Gupta, Richard Creger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2002
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
Ashwin Kashyap, John Wingard, Pablo Cagnoni, et al.
Blood
|
January 17, 2012
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
Roy F Chemaly, Santosh S Hanmod, Dhanesh B Rathod, et al.
Blood
|
December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations
Elias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 24, 2007
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes
Anna V Christoforidou, Rima M Saliba, Patricia Williams, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
Amir Hamdi, Raya Mawad, Roland Bassett, et al.
Blood
|
April 20, 2004
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
Marcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 217) with videos related to
Sort By:
Page
of 22
BMJ Supportive & Palliative Care
|
September 2, 2017
Risk factors for falls in older patients with cancer
Xiaotao Zhang, Ming Sun, Suyu Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Joseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Blood Advances
|
April 12, 2024
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies
Supawee Saengboon, Stefan Ciurea, Uday Popat, et al.
Leukemia & Lymphoma
|
January 4, 2018
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma
Ehsan Malek, Vinita Gupta, Richard Creger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 11, 2002
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
Ashwin Kashyap, John Wingard, Pablo Cagnoni, et al.
Blood
|
January 17, 2012
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
Roy F Chemaly, Santosh S Hanmod, Dhanesh B Rathod, et al.
Blood
|
December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations
Elias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 24, 2007
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes
Anna V Christoforidou, Rima M Saliba, Patricia Williams, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
Amir Hamdi, Raya Mawad, Roland Bassett, et al.
Blood
|
April 20, 2004
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
Marcos de Lima, Athanasios Anagnostopoulos, Mark Munsell, et al.
Page
of 22